Filing Details

Accession Number:
0001179110-17-009057
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-14 14:40:43
Reporting Period:
2017-06-13
Filing Date:
2017-06-14
Accepted Time:
2017-06-14 14:40:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1109354 Bruker Corp BRKR Laboratory Analytical Instruments (3826) 043110160
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1142622 Richard Kniss C/O Alameda Investments
1985 Cowper Street
Palo Alto CA 94301
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-13 6,000 $12.09 46,753 No 4 M Direct
Common Stock Acquisiton 2017-06-13 6,000 $4.13 52,753 No 4 M Direct
Common Stock Acquisiton 2017-06-13 6,000 $12.48 58,753 No 4 M Direct
Common Stock Acquisiton 2017-06-13 6,000 $16.09 64,753 No 4 M Direct
Common Stock Disposition 2017-06-13 24,000 $28.23 40,753 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-06-13 6,000 $0.00 6,000 $12.09
Common Stock Stock Option Disposition 2017-06-13 6,000 $0.00 6,000 $4.13
Common Stock Stock Option (right to buy) Disposition 2017-06-13 6,000 $0.00 6,000 $12.48
Common Stock Stock Option (right to buy) Disposition 2017-06-13 6,000 $0.00 6,000 $16.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-01-07 No 4 M Direct
0 2019-01-07 No 4 M Direct
0 2020-01-05 No 4 M Direct
0 2021-01-05 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.16 to $28.32, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The options exercised vested in three annual installments on the anniversary of the grant date commencing January 7, 2009.
  3. The options exercised vested in three annual installments on the anniversary of the grant date commencing January 7, 2010.
  4. The options exercised vested in three annual installments on the anniversary of the grant date commencing January 5, 2011.
  5. The options exercised vested in three annual installments on the anniversary of the grant date commencing January 5, 2012.